Sign In
Buy GERN
$1.34
+0.0600 (+4.69%)
At Close: Aug 04, 2026
NEW YORK, NY / ACCESS Newswire / April 1, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities law
NEW YORK, NY / ACCESS Newswire / April 1, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities law
Lost Money on Geron Corporation(GERN)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
03:45pm, Tuesday, 01'st Apr 2025
NEW YORK, NY / ACCESS Newswire / April 1, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities law
NEW YORK CITY, NY / ACCESS Newswire / April 1, 2025 / WHY: New York, N.Y., April 1, 2025.
Levi & Korsinsky Notifies Shareholders of Geron Corporation (GERN) of a Class Action Lawsuit and an Upcoming Deadline
01:22pm, Tuesday, 01'st Apr 2025
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Geron Corporation ("Geron" or the "Company") (NASDAQ: GERN) of a class action securities lawsuit.
Class Action Filed Against Geron Corporation (GERN) - May 12, 2025 Deadline to Join - Contact Levi & Korsinsky
12:30pm, Tuesday, 01'st Apr 2025
NEW YORK CITY, NY / ACCESS Newswire / April 1, 2025 / NEW YORK, NY / ACCESS Newswire / April 1, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers - GERN
11:55am, Tuesday, 01'st Apr 2025
NEW YORK CITY, NY / ACCESS Newswire / April 1, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Geron Corporation ("Geron" or the "Company") (NASDAQ:GERN) and certain
Shareholders of Geron Corporation Should Contact Levi & Korsinsky Before May 12, 2025 to Discuss Your Rights - GERN
07:25am, Tuesday, 01'st Apr 2025
NEW YORK, NY / ACCESS Newswire / April 1, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities law
NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Geron Corpo
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 12, 2025 in Geron Corporation Lawsuit - GERN
05:45am, Tuesday, 01'st Apr 2025
NEW YORK , April 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Geron Corporation ("Geron" or the "Company") (NASDAQ: GERN) of a class action securities lawsuit. CLASS DEFINITION
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Geron Corporation (GERN) Shareholders
07:45pm, Monday, 31'st Mar 2025
NEW YORK, NY / ACCESS Newswire / March 31, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities la
RADNOR, Pa. , March 31, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against Geron
Contact Levi & Korsinsky by May 12, 2025 Deadline to Join Class Action Against Geron Corporation(GERN)
05:15pm, Monday, 31'st Mar 2025
NEW YORK, NY / ACCESS Newswire / March 31, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities la
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Geron Corporation (NASDAQ: GERN) securities between February 28, 2024 and Febru
Geron Corp.: A Compelling Potential Buying Opportunity Thanks To Bearish Comments
04:32pm, Monday, 31'st Mar 2025
GERN's Rytelo showed promising sales growth, with Q4'24 net product revenue increasing by 68% to $47.5M from Q3'24's $28.2M. Despite initial optimism, the market is concerned about a potential plateau
